(Q36661811)

15 August 2017

1 reference

title

Genetic risk factors for inhibitors to factors VIII and IX. (English)

1 reference

15 August 2017

Oldenburg J

1

1 reference

PubMed ID

17123389

15 August 2017

Pavlova A

series ordinal

2

1 reference

15 August 2017

1 December 2006

1 reference

15 August 2017

1 reference

15 August 2017

12 Suppl 6

1 reference

15 August 2017

15-22

1 reference

Environmental and genetic factors influencing inhibitor development

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01361.X

Molecular etiology of factor VIII deficiency in hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01361.X

Factor IX inhibitors and anaphylaxis in hemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01361.X

Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01361.X

Inhibitor development in correlation to factor VIII genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01361.X

The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor development in hemophilia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01361.X

Incidence of inhibitors in haemophilia A patients--a review of recent studies of recombinant and plasma-derived factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01361.X

The factor VIII Structure and Mutation Resource Site: HAMSTeRS version 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01361.X

Factor VIII inhibitors in mild and moderate-severity haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01361.X

Haemophilia B: database of point mutations and short additions and deletions--eighth edition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01361.X

The endogenous pathway of MHC class II antigen presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01361.X

CD28/B7 system of T cell costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01361.X

MHC ligands and peptide motifs: first listing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01361.X

Cellular immune responses in hemophilia: why do inhibitors develop in some, but not all hemophiliacs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01361.X

Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01361.X

Tumor necrosis factor alpha in autoimmunity: pretty girl or old witch?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2006.01361.X

10.1111/J.1365-2516.2006.01361.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17123389